Loading...
XSHE002614
Market cap512mUSD
Jan 10, Last price  
6.03CNY
1D
-5.49%
1Q
-0.33%
Jan 2017
-54.80%
IPO
-38.05%
Name

Xiamen Comfort Science & Technology Group Co Ltd

Chart & Performance

D1W1MN
XSHE:002614 chart
P/E
36.43
P/S
0.75
EPS
0.17
Div Yield, %
5.75%
Shrs. gr., 5y
1.26%
Rev. gr., 5y
-1.58%
Revenues
5.03b
-16.50%
1,087,665,9821,188,472,1511,302,691,7781,829,852,2271,886,839,5841,771,659,8802,229,978,3422,811,257,7992,830,727,1913,451,383,1924,293,808,6525,447,030,7145,276,271,2527,049,158,3517,926,722,1926,024,336,7065,030,460,330
Net income
103m
+1.16%
88,175,35846,024,31593,970,114153,076,726138,440,89227,390,800104,347,429140,218,107180,553,948251,030,468345,180,248439,121,842288,977,759439,275,937458,358,173102,022,883103,203,187
CFO
895m
+20.62%
126,173,99278,682,262147,800,819146,054,644048,654,754228,880,186142,555,667141,961,366119,162,503302,733,835475,649,343276,344,951714,610,9480742,083,023895,115,087
Dividend
May 29, 20240.3 CNY/sh
Earnings
May 20, 2025

Profile

Xiamen Comfort Science&Technology Group Co., Ltd researches, develops, manufactures, and sells health massage appliances in China and internationally. The company provides massage chairs and appliances, humidifier, air purifiers, fresh air systems, blood pressure monitors, oximeters, laser hair removal devices, sports bracelets, other home medical products, etc. It offers its products primarily under the OGAWA, FUJI, FUJIMEDIC, COZZIA, MEDISANA, EASEWELL, ihoco, SHUSIJIA, and ETRO brand names. The company was formerly known as Xiamen Comfort Science&Technology Group Co., Ltd. and changed its name to Ogawa Smart Healthcare Technology Group Co., Ltd. in May 2017. The company was founded in 1996 and is based in Xiamen, China.
URL
https://www.easepal.com.cn/
IPO date
Sep 09, 2011
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
5,030,460
-16.50%
6,024,337
-24.00%
Cost of revenue
4,019,385
5,534,040
Unusual Expense (Income)
NOPBT
1,011,075
490,297
NOPBT Margin
20.10%
8.14%
Operating Taxes
39,113
56,492
Tax Rate
3.87%
11.52%
NOPAT
971,962
433,805
Net income
103,203
1.16%
102,023
-77.74%
Dividends
(216,336)
(186,849)
Dividend yield
4.75%
3.21%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
437,281
264,131
Long-term debt
772,000
1,077,648
Deferred revenue
2
Other long-term liabilities
17,633
14,811
Net debt
(1,718,916)
(2,060,180)
Cash flow
Cash from operating activities
895,115
742,083
CAPEX
(246,264)
Cash from investing activities
(433,177)
Cash from financing activities
FCF
923,500
846,377
Balance
Cash
2,839,266
3,401,959
Long term investments
88,932
Excess cash
2,676,674
3,100,742
Stockholders' equity
2,737,313
3,125,202
Invested Capital
3,069,493
2,903,936
ROIC
32.54%
13.22%
ROCE
17.52%
8.12%
EV
Common stock shares outstanding
607,078
623,469
Price
7.50
-19.61%
9.33
-27.56%
Market cap
4,553,082
-21.73%
5,816,964
-33.00%
EV
2,858,701
3,918,667
EBITDA
1,308,647
760,790
EV/EBITDA
2.18
5.15
Interest
57,737
62,685
Interest/NOPBT
5.71%
12.79%